Scientists Identify New Stem Cell Type as Key Biological Driver of Age-Related Belly Fat
Researchers have discovered a unique class of stem cells that awaken in middle age to actively generate new abdominal fat cells, fundamentally shifting our understanding of age-related weight gain.
By Factlen Editorial Team
- Metabolic Researchers
- Focus on the discovery of the LIFR pathway and its potential as a direct therapeutic target for age-related obesity.
- Longevity Scientists
- Emphasize the biological paradox of stem cells gaining hyperactive function with age rather than experiencing cellular exhaustion.
- Public Health Advocates
- Highlight the severe metabolic risks of visceral fat and stress that lifestyle interventions remain critical while drugs are developed.
What's not represented
- · Pharmaceutical developers evaluating the commercial viability of LIFR-blocking drugs.
- · Dietitians and nutritionists adapting dietary guidelines to account for age-specific cellular fat production.
Why this matters
This discovery proves that middle-aged weight gain is driven by a specific, targetable cellular mechanism rather than just a slowing metabolism, paving the way for therapies that could prevent age-related obesity and diabetes.
Key points
- Researchers discovered a new type of stem cell (CP-As) that emerges in middle age.
- Unlike young stem cells, CP-As actively and continuously generate new belly fat cells.
- This process occurs independently of changes in diet or exercise routines.
- The LIFR signaling pathway was identified as the trigger that activates these cells.
- Blocking the LIFR pathway in animal models successfully halted age-related visceral fat expansion.
- The discovery provides a new therapeutic target for preventing age-related obesity and metabolic disease.
It is a nearly universal human experience: as people enter their forties and fifties, the midsection begins to soften and expand, often without any significant changes to diet or exercise routines. For decades, this frustrating reality was accepted as an inevitable consequence of getting older.[3]
The medical consensus long attributed this shift to a vague combination of slowing metabolic rates, hormonal fluctuations, and a gradual decline in daily physical activity. The prevailing assumption was that existing fat cells simply swelled to accommodate excess energy, a biological process known as hypertrophy.[4]
However, a landmark study published in the journal Science has fundamentally rewritten the biological rulebook on age-related weight gain. Researchers have discovered that our bodies actually begin manufacturing entirely new fat cells in middle age, driven by a newly identified class of hyperactive stem cells.[1]
The discovery, spearheaded by researchers at City of Hope and UCLA, shifts the blame for middle-aged belly fat from purely lifestyle factors to a concrete, targetable cellular mechanism. It provides a biological explanation for why the body's composition changes even when the number on the scale remains stable.[2][5]

To understand the breakthrough, it is necessary to look at adipocyte progenitor cells, or APCs. These are the adult stem cells residing in white adipose tissue that serve as the biological "seeds" for future fat cells.[1]
In young bodies, these stem cells are relatively dormant. They only activate and mature into fat cells when the body is forced to store a massive surplus of caloric energy. Otherwise, they remain quiet, keeping the production of new fat cells tightly regulated.[2]
But as the body ages, a dramatic transformation occurs. The researchers discovered that aging triggers these dormant cells to evolve into a distinct, highly active sub-population called "committed preadipocytes, age-specific," or CP-As.[1]
Unlike their youthful counterparts, CP-A cells do not wait for a caloric surplus to activate. Instead, they become "super-producers," actively and continuously churning out new fat cells at a colossal rate, specifically within the deep visceral fat of the abdomen.[2]

This finding presents a fascinating and somewhat troubling paradox in the field of aging biology. Most adult stem cells—such as those responsible for repairing skin, regenerating bone, or maintaining muscle—experience "cellular exhaustion" and lose their functional capacity as we get older.[4]
This finding presents a fascinating and somewhat troubling paradox in the field of aging biology.
The stem cells responsible for abdominal fat, however, do the exact opposite. While most adult stem cells' capacity to grow wanes with age, aging actually unlocks these specific cells' power to evolve, multiply, and spread throughout the midsection.[2]
To prove that this was an intrinsic property of the aging cells and not just a reaction to an older body's environment, the research team performed a crucial experiment. They transplanted the age-specific CP-A stem cells from older animal models into the bodies of young, lean subjects.[1]
The results were striking. Even in the youthful environment, the transplanted older stem cells rapidly generated massive amounts of new fat cells, proving that the cells themselves had been permanently reprogrammed by age to overproduce fat.[1][5]

The researchers did not stop at identifying the cells; they also uncovered the chemical switch that turns them on. Through advanced single-cell RNA sequencing, they pinpointed a specific signaling pathway called the leukemia inhibitory factor receptor, or LIFR.[1]
The LIFR pathway acts as the biological engine driving the CP-A cells to multiply and differentiate into mature fat cells. When the researchers successfully blocked the LIFR signal in animal models, the age-related expansion of visceral fat was completely halted.[2]
Importantly, the team validated these findings in human tissue samples, confirming that middle-aged humans harbor the exact same hyperactive CP-A stem cells as the animal models, operating under the same biological directives.[1]
The implications of this discovery extend far beyond cosmetic concerns about fitting into older clothing. Visceral fat—the deep abdominal fat that wraps around internal organs—is highly metabolically active and constantly secretes inflammatory molecules into the bloodstream.[6]

This specific type of fat is a primary driver of insulin resistance, cardiovascular disease, and accelerated systemic aging. By identifying the cellular source of visceral fat, scientists now have a precise target for therapies aimed at preventing age-related metabolic decline.[4][6]
Developing a pharmaceutical intervention that safely blocks the LIFR pathway or selectively neutralizes CP-A cells could theoretically stop the middle-aged spread before it starts, offering a new frontier in preventative medicine and longevity science.[3]
While such targeted therapies remain years away from clinical availability, the discovery provides immediate validation for millions of adults. It confirms that the sudden accumulation of belly fat in middle age is driven by a powerful biological shift, not merely a lack of willpower.[3]
How we got here
Early 2000s
Scientists establish that adult stem cells generally lose their regenerative capacity as the body ages.
2010s
Research confirms that visceral fat accumulation in middle age is a primary driver of metabolic syndrome and cardiovascular disease.
2024
Single-cell RNA sequencing technology allows researchers to map the exact genetic changes in fat tissue stem cells over time.
May 2025
City of Hope and UCLA researchers publish breakthrough findings in Science, identifying the CP-A stem cell and the LIFR pathway.
2026
The discovery shifts the focus of obesity research toward developing targeted therapies that block the LIFR signal to prevent age-related weight gain.
Viewpoints in depth
Metabolic Researchers' view
Targeting the cellular root of age-related weight gain.
For metabolic researchers, the discovery of CP-A stem cells represents a paradigm shift in how we treat obesity in older adults. By identifying the leukemia inhibitory factor receptor (LIFR) as the specific signaling pathway that commands these cells to multiply, scientists now have a precise molecular target. The goal is no longer just managing the energy balance of existing fat cells, but developing pharmaceutical interventions that can safely block the LIFR signal, effectively turning off the body's age-induced fat factory before visceral fat can accumulate.
Longevity Scientists' view
A paradox in the standard model of cellular aging.
Longevity experts view this discovery as a fascinating contradiction to the established rules of biological aging. The standard model dictates that adult stem cells—which repair skin, muscle, and bone—suffer from 'cellular exhaustion' and lose their functional capacity over time. However, CP-A stem cells do the exact opposite, gaining hyperactive function and becoming 'super-producers' in middle age. Understanding why this specific population of cells escapes the normal decline of aging could unlock broader secrets about cellular reprogramming and tissue regeneration.
Public Health Advocates' view
Balancing future cures with current realities.
While public health officials welcome the breakthrough, they emphasize the immediate, compounding dangers of visceral fat, which actively secretes inflammatory cytokines and drives insulin resistance. Because targeted LIFR-blocking therapies are still years away from clinical availability, these advocates stress that the discovery should not lead to fatalism. They argue that maintaining lean muscle mass through resistance training and optimizing cardiovascular health remain the most effective, evidence-based tools currently available to counteract the body's biological shift toward fat production.
What we don't know
- Whether the LIFR signaling pathway can be safely blocked in humans without causing unintended side effects in other tissues.
- How hormonal changes during menopause specifically interact with CP-A stem cells, as the initial human tissue samples were predominantly male.
- The exact timeline of when CP-A cells first begin to emerge in the human aging process.
Key terms
- Adipocyte Progenitor Cells (APCs)
- Adult stem cells residing in fat tissue that serve as the precursors to mature fat cells.
- CP-As (Committed Preadipocytes, Age-specific)
- A newly discovered sub-type of stem cell that emerges in middle age and aggressively produces new fat cells.
- Visceral Fat
- Deep abdominal fat that surrounds internal organs and is strongly linked to metabolic diseases.
- Hyperplasia
- The enlargement of a tissue caused by an increase in the reproduction rate of its cells, resulting in entirely new cells.
- Hypertrophy
- The enlargement of a tissue resulting from the increase in size of its existing cells.
- LIFR Pathway
- A cellular signaling mechanism identified as the critical driver that commands CP-A cells to multiply.
Frequently asked
Why do we gain belly fat as we age even if we eat the same?
Aging triggers a specific type of stem cell (CP-As) to become hyperactive, continuously generating new fat cells in the abdomen regardless of caloric intake.
Is visceral fat just a cosmetic issue?
No. Visceral belly fat surrounds internal organs and releases inflammatory molecules, significantly increasing the risk of diabetes, heart disease, and accelerated aging.
Can we stop these stem cells from making fat?
Researchers have identified the signaling pathway (LIFR) that drives them. Blocking this pathway in animal models stopped the fat accumulation, paving the way for future human therapies.
What can I do about it right now?
While targeted drugs are still in development, maintaining lean muscle mass through resistance training and staying physically active remain the best ways to counteract this biological shift.
Sources
[1]ScienceMetabolic Researchers
Distinct adipose progenitor cells emerging with age drive active adipogenesis
Read on Science →[2]City of HopeMetabolic Researchers
Aging triggers new adult stem cell that drives massive production of belly fat
Read on City of Hope →[3]Factlen Editorial TeamLongevity Scientists
Synthesis by Factlen editorial team
Read on Factlen Editorial Team →[4]National Institutes of HealthPublic Health Advocates
Age-related changes in adipose tissue distribution and function
Read on National Institutes of Health →[5]UCLA HealthLongevity Scientists
UCLA researchers collaborate on discovery of age-specific fat stem cells
Read on UCLA Health →[6]American Diabetes AssociationPublic Health Advocates
Visceral Fat and Insulin Resistance: The Biological Link
Read on American Diabetes Association →
Every angle. Every day.
Get health stories with full source coverage and perspective breakdowns delivered to your inbox.








